Mucosal inflammation in severe glucocorticoid-dependent asthma

To improve our understanding of the inflammatory mechanisms underlying severe disease, a biopsy study was performed comparing 15 clinically unstable glucocorticoid-dependent asthmatics, 10 mild asthmatics, and 10 control subjects. Compared with mild asthma, severe asthma was characterized by reduced mucosal eosinophilia. Whilst no significant differences were found in the numbers of mast cells, neutrophils, CD3+ and CD4+ T-cells between the three groups, up to a 4-fold increase In the numbers of activated T-lymphocytes bearing the interleukin (IL)-2 receptor (IL-2R) was found in the mucosa in severe asthma compared to mild asthma (p = 0.03) and control subjects (p = 0.003). Compared to control subjects, the mucosa of severe asthmatics contained significantly (p = 0.02) higher numbers of IL-5+ cells, with no differences between mild and severe disease. In contrast, staining for the anti-IL-4 monoclonal antibody 3H4 revealed that biopsies from mild asthmatics contained more IL4+ cells than biopsies from severe asthmatics and control subjects (p = 0.0008). In the severe asthmatics, a close correlation (r(s) = 0.76, p = 0.005) was found between the numbers of IL-2R-bearing cells and the variability in peak expiratory flow. In conclusion, persistent T-cell activation is a prominent feature of severe asthma. These results also indicate that interleukin-5, and not interleukin-4, is upregulated in severe disease.

This article has been cited by other articles:

				Y.-K. Kim, S.-Y. Oh, S. G. Jeon, H.-W. Park, S.-Y. Lee, E.-Y. Chun, B. Bang, H.-S. Lee, M.-H. Oh, Y.-S. Kim, et al. Airway Exposure Levels of Lipopolysaccharide Determine Type 1 versus Type 2 Experimental Asthma J. Immunol., April 15, 2007; 178(8): 5375 - 5382. [Abstract] [Full Text] [PDF]

				P. Chanez, A. Bourdin, I. Vachier, P. Godard, J. Bousquet, and A. M. Vignola Effects of Inhaled Corticosteroids on Pathology in Asthma and Chronic Obstructive Pulmonary Disease Proceedings of the ATS, November 1, 2004; 1(3): 184 - 190. [Abstract] [Full Text] [PDF]

				R. Gagliardo, P. Chanez, M. Mathieu, A. Bruno, G. Costanzo, C. Gougat, I. Vachier, J. Bousquet, G. Bonsignore, and A. M. Vignola Persistent Activation of Nuclear Factor-{kappa}B Signaling Pathway in Severe Uncontrolled Asthma Am. J. Respir. Crit. Care Med., November 15, 2003; 168(10): 1190 - 1198. [Abstract] [Full Text] [PDF]

				P. Jeffery, S. Holgate, and S. Wenzel Methods for the Assessment of Endobronchial Biopsies in Clinical Research: Application to Studies of Pathogenesis and the Effects of Treatment Am. J. Respir. Crit. Care Med., September 15, 2003; 168(6): S1 - 17. [Full Text] [PDF]

				L. Benayoun, A. Druilhe, M.-C. Dombret, M. Aubier, and M. Pretolani Airway Structural Alterations Selectively Associated with Severe Asthma Am. J. Respir. Crit. Care Med., May 15, 2003; 167(10): 1360 - 1368. [Abstract] [Full Text] [PDF]

				S. J. Gardai, R. Hoontrakoon, C. D. Goddard, B. J. Day, L. Y. Chang, P. M. Henson, and D. L. Bratton Oxidant-Mediated Mitochondrial Injury in Eosinophil Apoptosis: Enhancement by Glucocorticoids and Inhibition by Granulocyte-Macrophage Colony-Stimulating Factor J. Immunol., January 1, 2003; 170(1): 556 - 566. [Abstract] [Full Text] [PDF]

				P. G. Gibson, J. L. Simpson, and N. Saltos Heterogeneity of Airway Inflammation in Persistent Asthma : Evidence of Neutrophilic Inflammation and Increased Sputum Interleukin-8 Chest, May 1, 2001; 119(5): 1329 - 1336. [Abstract] [Full Text] [PDF]

				R. GAGLIARDO, P. CHANEZ, A. M. VIGNOLA, J. BOUSQUET, I. VACHIER, P. GODARD, G. BONSIGNORE, P. DEMOLY, and M. MATHIEU Glucocorticoid Receptor alpha and beta in Glucocorticoid Dependent Asthma Am. J. Respir. Crit. Care Med., July 1, 2000; 162(1): 7 - 13. [Abstract] [Full Text]

				H. Ochi, N. H. De Jesus, F. H. Hsieh, K. F. Austen, and J. A. Boyce IL-4 and -5 prime human mast cells for different profiles of IgE-dependent cytokine production PNAS, September 12, 2000; 97(19): 10509 - 10513. [Abstract] [Full Text] [PDF]